The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck; MSD; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; SERVIER
Research Funding - Bristol-Myers Squibb; MSD; SERVIER
Travel, Accommodations, Expenses - Amgen; Merck; SERVIER

Checkmate 577:Health-related quality of life (HRQoL) in a randomized, double-blind phase III study of nivolumab (NIVO) versus placebo (PBO) as adjuvant treatment in patients (pts) with resected esophageal or gastroesophageal junction cancer (EC/GEJC).
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Biocartis; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; GlaxoSmithKline; Halozyme; Incyte; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Prianka Singh
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
James M. Cleary
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbvie (Inst); AstraZeneca; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Esperas Pharma; Merck; Merus (Inst); Roche/Genentech (Inst); Tesaro
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Roche
 
Ronan Joseph Kelly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Medscape; Merck; Novartis; Pieris Pharmaceuticals; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Servier; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; MSD; Nordic Group; Pfizer; Roche; SERVIER; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; ESMO; German Cancer Society; Merck Serono; MSD; Roche
 
Jaroslaw Kuzdzal
Honoraria - Bristol-Myers Squibb; Roche
Research Funding - Bristol Myers Squibb Foundation; Roche
 
Guillermo Mendez
No Relationships to Disclose
 
Satoru Motoyama
No Relationships to Disclose
 
Elena Elimova
Employment - Merck (I)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Zymeworks (Inst)
Research Funding - Bristol-Myers Squibb; Zymeworks
 
Cecile Grootscholten
No Relationships to Disclose
 
Xiaowu Sun
Employment - Adelphi
 
Fiona Taylor
Employment - mployee of Adelphi Values, a consulting firm who has received payment from BMS for statistical data analysis in BMS' trials
 
Rachael Lawrance
Employment - Adelphi
Stock and Other Ownership Interests - AstraZeneca
 
Brad Padilla
Employment - Adelphi
 
Alejandro Moreno-Koehler
Employment - Adelphi
 
Jenny Zhang
No Relationships to Disclose
 
Steven I. Blum
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jaffer A. Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DAVA Pharmaceuticals; Lilly; Merck; zymeworks
Consulting or Advisory Role - American Cancer Society; BeiGene; Bristol-Myers Squibb; Insys Therapeutics; Merck; Vaccinogen
Research Funding - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly